A Phase 2a Study to Evaluate the Safety and Efficacy of Tegoprubart (AT-1501) in Patients With IgA Nephropathy (IgAN)

被引：0
|
作者：
Barratt, Jonathan [1 ]
Liew, Adrian [9 ]
Rizk, Dana [3 ]
Willcocks, Lisa [10 ]
Lafayette, Richard A. [4 ]
Wong, Muh Geot [7 ]
Tesar, Vladimir [6 ]
Bornstein, Jeffrey D. [2 ]
Reich, Heather N. [5 ]
Tang, Sydney C. [8 ]
机构：
[1] Univ Leicester, Leicester, Leics, England
[2] Eledon Pharmaceut, Irvine, CA USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[5] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[6] Univ Karlova, Prague, Czech Republic
[7] Univ Sydney, Sydney, NSW, Australia
[8] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Peoples R China
[9] Mt Elizabeth Med Ctr, Singapore, Singapore
[10] Addenbrookes Hosp, Cambridge, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO498
引用
收藏
页码：187 / 188
页数：2
相关论文
共 50 条
  • [1] A Phase 1b, Multicenter, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Tegoprubart (AT-1501) in Patients Undergoing Kidney Transplant
    Tchervenkov, Jean
    Coates, Patrick T.
    Kadatz, Matthew J.
    Bornstein, Jeffrey D.
    Gill, John S.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 967 - 967
  • [2] A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of At-1501
    Perrin, S.
    Gill, A.
    Gill, C.
    Gustafson, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 430 - 431
  • [3] EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IGAN STUDY
    Rizk, Dana V.
    Kollins, Dmitrij
    Papachristofi, Olympia
    Hach, Thomas
    Jacinto-Sanders, Severina
    Merkel, Tobias
    Renfurm, Ronny
    Perkovic, Vlado
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (05) : 699 - 700
  • [4] Efficacy and safety of iptacopan in patients with primary IgA nephropathy: interim analysis results of the Phase 3 APPLAUSE-IgAN study
    Perkovic, Vlado
    Kollins, Dmitrij
    Papachristofi, Olympia
    Hach, Thomas
    Jacinto-Sanders, Severina
    Merkel, Tobias
    Renfurm, Ronny
    Rizk, Dana V.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I255 - I256
  • [5] Efficacy and safety of Telitacicept in patients with IgA nephropathy
    Liang, Dongrui
    Li, Xiaodong
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (06) : 1897 - 1897
  • [6] THE ROLE OF GLIADIN IN IGA NEPHROPATHY (IGAN) - AN IMMUNOPEROXIDASE STUDY OF BRITISH AND SINGAPORE PATIENTS
    DODD, S
    KHAN, TN
    MOORE, R
    SINNIAH, R
    [J]. JOURNAL OF PATHOLOGY, 1991, 163 (02): : A166 - A166
  • [7] Efficacy and safety of telitacicept in IgA nephropathy: a retrospective study
    Pan, Yuting
    Yan, Miao
    Wang, Huiming
    Chen, Cheng
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2148 - I2150
  • [8] The efficacy and safety of hydroxychloroquine in pregnant patients with IgA nephropathy: A retrospective cohort study
    Tang, Chen
    Si, Feng-Lei
    Yao, Yu-Xuan
    Lv, Ji-Cheng
    Shi, Su-Fang
    Chen, Yu-Qing
    Liu, Li-Jun
    Zhang, Hong
    [J]. NEPHROLOGY, 2022, 27 (02) : 155 - 161
  • [9] A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AT1501
    Perrin, Steven
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 455 - 455
  • [10] A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Patients With IgA Nephropathy
    Rizk, Dana
    Perkovic, Vlado
    Lafayette, Richard A.
    Trimarchi, Hernan
    Barratt, Jonathan
    Carroll, Kevin
    Tesar, Vladimir
    Zhang, Hong
    Suzuki, Yusuke
    Liew, Adrian
    Wong, Muh Geot
    Leslie, Bruce R.
    Mathur, Mohit
    Hafkin, Jeffrey
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 799 - 799
12345